Regen BioPharma Inc is a Nevada-incorporated biopharmaceutical company focused on developing regenerative medical applications. Its pipeline includes HemaXellerate (autologous SVF cells for aplastic anemia), dCellVax and tCellVax (dendritic and T-cell cancer immunotherapies), DiffronC (siRNA-based cancer treatment), DuraCar (CAR-T cells with NR2F6 shRNA inhibition), and small molecule NR2F6 modulators. The company develops products through Phase I/II clinical trials, then seeks to sell, license, or advance them further.
Q2 FY2026 — expected 2026-09-17
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-12-30 | 2025-09-30 | 0001493152-25-029526 | EDGAR | 38K words |
| 2025-05-13 | 2024-09-30 | 0001641172-25-009968 | EDGAR | 37K words |
| 2023-11-20 | 2023-09-30 | 0001607062-23-000524 | EDGAR | 40K words |
| 2022-11-15 | 2022-09-30 | 0001607062-22-000694 | EDGAR | 50K words |
| 2021-12-22 | 2021-09-30 | 0001607062-21-000641 | EDGAR | 62K words |
| 2021-08-04 | 2020-09-30 | 0001607062-21-000250 | EDGAR | 67K words |
| 2021-06-21 | 2019-09-30 | 0001607062-21-000165 | EDGAR | 71K words |
| 2018-12-27 | 2018-09-30 | 0001607062-18-000491 | EDGAR | 74K words |
| 2018-01-05 | 2017-09-30 | 0001607062-18-000006 | EDGAR | 75K words |
| 2016-12-21 | 2016-09-30 | 0001607062-16-001092 | EDGAR | 51K words |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-17 | 2026-06-30 | 0001493152-26-038576 | EDGAR | 23K words |
| 2026-02-13 | 2025-12-31 | 0001493152-26-006526 | EDGAR | 17K words |
| 2025-08-11 | 2025-06-30 | 0001641172-25-022884 | EDGAR | 21K words |
| 2025-05-28 | 2025-03-31 | 0001641172-25-012619 | EDGAR | 15K words |
| 2025-05-16 | 2024-12-31 | 0001641172-25-011206 | EDGAR | 15K words |
| 2024-08-13 | 2024-06-30 | 0001607062-24-000238 | EDGAR | 21K words |
| 2024-04-24 | 2024-03-31 | 0001607062-24-000131 | EDGAR | 19K words |
| 2024-01-19 | 2023-12-31 | 0001607062-24-000033 | EDGAR | 18K words |
| 2023-07-25 | 2023-06-30 | 0001607062-23-000371 | EDGAR | 21K words |
| 2023-04-18 | 2023-03-31 | 0001607062-23-000215 | EDGAR | 20K words |
| 2023-01-19 | 2022-12-31 | 0001607062-23-000028 | EDGAR | 19K words |
| 2022-07-22 | 2022-06-30 | 0001607062-22-000477 | EDGAR | 34K words |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-07-15 | 0001493152-26-033364 | EDGAR | 4K words |
| 2026-03-04 | 0001493152-26-008837 | EDGAR | 1K words |
| 2026-02-02 | 0001493152-26-004733 | EDGAR | 1K words |
| 2026-01-21 | 0001493152-26-002956 | EDGAR | 1K words |
| 2025-11-13 | 0001493152-25-022185 | EDGAR | 1K words |
| 2025-10-03 | 0001493152-25-016767 | EDGAR | 1K words |
| 2025-09-19 | 0001493152-25-014182 | EDGAR | 1K words |
| 2025-08-07 | 0001641172-25-022575 | EDGAR | 11K words |
| 2025-08-01 | 0001641172-25-021882 | EDGAR | 4K words |
| 2025-06-11 | 0001641172-25-014652 | EDGAR | 1K words |
197 total filings indexed. 165 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001589150 |
| Ticker | RGBP |
| Exchange | OTC |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | NV |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/RGBP (~200 tokens, structured JSON with cryptographic provenance)